CBI-101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCBI-101
Drug Alias NameCBI-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor agonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCarolina Biopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCarolina Biopharm
Active IndicationsN/A
Inactive IndicationsSarcoma

Other Information

ATC CodeN/A
Related LinksN/A